Sopharma AD (SPH)

SPH Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022

SPH Sales revenues for February 2024

SPH Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212

SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase

SPH Consolidated financial report as of 31 December 2023

SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212

SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants

SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition

SPH NOTIFICATION OF INSIDERS’ TRANSACTIONS under art. 19 of Regulation 596/2014 for subscribin shares from a temporary issue/exercising warrants

SPH Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 as of 20 February 2024 re exercising warrants

SPH Notification from Ognian Donev under Art. 19 of Regulation (EU) 596/2014 for subscribing sharesd form a temporary issue/exercising warrants on 19 February 2024

SPH Notification from Ognian Donev in accordance with art. 19 from Regulation 596/2014 for exercising warrants on 19 February 2024

SPH Notification for Sales revenues for January 2024

SPH Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024

SPH Individual financial report according to IFRS as of 31 December 2023

SPH Notification according to Art. 89t of the LPOS concerning an increase of the capital of "SOFARMA" AD, UIC 831902088, with registered office and management address in the city of Sofia, Nadezhda district, 16 Iliensko shose Str. by exercising warrants from the issue with ISIN BG9200001212

SPH Sopharma AD-Sofia presented Мinutes of the General Meeting of Warrant Holders held on 26-01-2024 11:00 a.m

SPH Sales revenues for December 2023

SPH Presentation of materials and Invitation for General Meeting of Warrant holders of Sopharma AD

SPH Merger of the subsidiary "Veta pharma" AD into "Sopharma" AD